BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Regulatory Affairs Professionals Society Webcast Tomorrow to Cover FDA-Compliant Off-label Info.


3/13/2012 2:40:04 PM

13 March 2012 -- The Regulatory Affairs Professionals Society (RAPS) will host a webcast tomorrow, 14 March, at 12:00 pm EDT, on how healthcare product companies may handle requests for off-label information while remaining in compliance with US Food and Drug Administration (FDA) requirements.

FDA has recently issued several draft guidances and clarifying statements about how to appropriately handle requests for off-label information, most recently in its December 2011 draft guidance, Responding to Unsolicited Requests for Off-label Information About Prescription Drugs and Medical Devices. This RAPS webcast, Providing Off-Label Information: FDA’s Latest Guidance, will provide an overview of all of FDA's guidances pertaining to this area. Dale Cooke, vice president/group director, Regulatory Review, Digitas Health and Razorfish Health, will explain how they fit together to give a comprehensive picture of how to provide information healthcare providers need while remaining compliant with the legal prohibition on marketing products for unapproved uses.

Who:

- Dale Cooke, vice president/group director, regulatory review, Digitas Health and Razorfish Health

- David Ralston, senior director of business conduct, Gilead Sciences

What:

90-minute webcast entitled Providing Off-Label Information: FDA’s Latest Guidance

When:

14 March, 12:00–1:30 pm EDT

How to Access:

Members of the working media may request access to this live RAPS webcast or to the recording by contacting Zachary Brousseau, senior manager, communications, RAPS, at zbrousseau@raps.org or +1 301 770 2920, ext. 245.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. Regulatory professionals play vital roles in making better healthcare products possible. They work throughout the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession by providing education and training, Regulatory Affairs Certification (RAC), professional standards, research, knowledge-sharing, publications, networking, career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS is headquartered near Washington, DC, with offices in Brussels and Tokyo. RAPS.org



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES